Hisamitsu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hisamitsu Pharmaceutical has a total shareholder equity of ¥275.9B and total debt of ¥1.1B, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are ¥350.5B and ¥74.6B respectively. Hisamitsu Pharmaceutical's EBIT is ¥13.8B making its interest coverage ratio -3.4. It has cash and short-term investments of ¥122.7B.
Key information
0.4%
Debt to equity ratio
JP¥1.12b
Debt
| Interest coverage ratio | -3.4x |
| Cash | JP¥122.74b |
| Equity | JP¥275.93b |
| Total liabilities | JP¥74.55b |
| Total assets | JP¥350.48b |
Recent financial health updates
Recent updates
Hisamitsu Pharmaceutical (TSE:4530) Has Announced A Dividend Of ¥45.00
Nov 08
We Think Hisamitsu Pharmaceutical (TSE:4530) Can Stay On Top Of Its Debt
Nov 04Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations
Oct 17Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing
Sep 16Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 20Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00
Jul 26Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year
Jul 11Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00
Jun 27Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00
Jun 13Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price
Apr 09Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching
Mar 18Financial Position Analysis
Short Term Liabilities: 4530's short term assets (¥207.0B) exceed its short term liabilities (¥58.6B).
Long Term Liabilities: 4530's short term assets (¥207.0B) exceed its long term liabilities (¥15.9B).
Debt to Equity History and Analysis
Debt Level: 4530 has more cash than its total debt.
Reducing Debt: 4530's debt to equity ratio has reduced from 0.7% to 0.4% over the past 5 years.
Debt Coverage: 4530's debt is well covered by operating cash flow (1664.5%).
Interest Coverage: 4530 earns more interest than it pays, so coverage of interest payments is not a concern.